Chimeric antigen receptor T-cell (CAR-T) cell therapy in Hungary in paediatric acute lymphoblastic leukaemia (ALL) and adult diffuse large B-cell lymphoma (DLBCL) disorders (Q3911376): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in de: Adding German translations) |
(Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string) |
||
| Property / beneficiary | |||
| Property / beneficiary: Q3965553 / rank | |||
Normal rank | |||
Revision as of 12:40, 9 December 2021
Project Q3911376 in Hungary
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chimeric antigen receptor T-cell (CAR-T) cell therapy in Hungary in paediatric acute lymphoblastic leukaemia (ALL) and adult diffuse large B-cell lymphoma (DLBCL) disorders |
Project Q3911376 in Hungary |
Statements
1,299,400,748 forint
0 references
94.999998 percent
0 references
1 February 2021
0 references
1 February 2023
0 references
DÉL-PESTI CENTRUMKÓRHÁZ-ORSZÁGOS HEMATOLÓGIAI ÉS INFEKTOLÓGIAI INTÉZET
0 references
47°29'30.62"N, 18°58'44.15"E
0 references
Budapest, Budapest
0 references
Identifiers
EFOP-5.2.6-20-2020-00010
0 references